21.44 +0.04 (0.19%)
KV.A
| Trade KV.A now with |
|
Stock Details
Last Trade:21.44 Change:+0.04 (0.19%) Prev Close:21.40 Open: 21.40 Days Range:21.36 – 21.50 52 Week Range: - Volume:24100 P/E: N/AEPS:
View AllRecent Alerts 02/09/12
Recent Alert on 01/20/12 at 3:40pm
FDA Panel votes 13-4 not to support Columbia Labs' (CBRX) preterm birth gel
FDA Panel votes 13-4 not to support Columbia Labs' (CBRX) preterm birth gel
FDA Panel votes 13-4 not to support Columbia Labs' (Nasdaq: CBRX) preterm birth gel.
Recent Alert on 01/20/12 at 3:40pm
FDA Panel votes 13-4 not to support Columbia Labs' (CBRX) preterm birth gel
FDA Panel votes 13-4 not to support Columbia Labs' (CBRX) preterm birth gel
Recent Alert on 01/20/12 at 3:03pm
FDA Panel Says Columbia Labs' (CBRX) Data on Preterm Birth Gel Isn't Sufficient (WPI)
FDA Panel Says Columbia Labs' (CBRX) Data on Preterm Birth Gel Isn't Sufficient (WPI)
Recent Alert on 01/20/12 at 3:03pm
FDA Panel Says Columbia Labs' (CBRX) Data on Preterm Birth Gel Isn't Sufficient (WPI)
FDA Panel Says Columbia Labs' (CBRX) Data on Preterm Birth Gel Isn't Sufficient (WPI)
Recent Alert on 01/20/12 at 3:03pm
FDA Panel Says Columbia Labs' (CBRX) Data on Preterm Birth Gel Isn't Sufficient (WPI)
FDA Panel Says Columbia Labs' (CBRX) Data on Preterm Birth Gel Isn't Sufficient (WPI)
View AllRecent Press Releases
Press Release on 02/09/12 at 7:30am
K-V Pharmaceutical Announces Updated Makena® Performance Metrics and Investor Conference Call
K-V Pharmaceutical Announces Updated Makena® Performance Metrics and Investor Conference Call
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 11/17/11 at 8:31am
KV Pharmaceuticals Facing Difficulty Overcoming Negative Sentiment Even With A New FDA Investigation
KV Pharmaceuticals Facing Difficulty Overcoming Negative Sentiment Even With A New FDA Investigation